A detailed history of Virtus ETF Advisers LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 47,708 shares of ALKS stock, worth $1.39 Million. This represents 1.07% of its overall portfolio holdings.

Number of Shares
47,708
Previous 6,901 591.32%
Holding current value
$1.39 Million
Previous $197,000 626.4%
% of portfolio
1.07%
Previous 0.3%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$26.13 - $30.46 $1.07 Million - $1.24 Million
40,807 Added 591.32%
47,708 $1.43 Million
Q1 2025

May 14, 2025

BUY
$28.08 - $36.0 $193,780 - $248,436
6,901 New
6,901 $227,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.77B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.